 Proactive Investors UK [1] |
GSK says diabetes treatment [2] [1] progressing in trials
Proactive Investors UK Pharmaceutical giant GlaxoSmithKline (LON:GSK) reported its diabetes treatment, albiglutide, has shown “topline results” in seven of its eight final stage studies. Albiglutide is an injectable form of the human peptide GLP-1 which helps maintain normal … GSK: Movement toward FDA filing with weekly diabetes treatment [3]HULIQ GlaxoSmithKline Drug Studies See Progression for Type-2 Diabetes Treatment [4]IBTimes.co.uk Glaxo To Seek OK For Diabetes Drug After Trial Results [5]Wall Street Journal China Post [6] –MedCity News [7] –MarketWatch [8] all 37 news articles » [9] |
More details can be found at www.diabeteshowto.com [10]